Posted by Michael Wonder on 06 May 2021
The difference between an interchangeable biosimilar and one that isn't
5 May 2021 - Permitting automatic substitution of biosimilars for originator brand biologics at the pharmacy counter is often talked about as a potential money saver.
Some integrated health care networks already direct pharmacists to intervene on prescriptions to ensure that biosimilars are substituted for higher-cost originator agents.
But although the FDA has approved 29 biosimilars, none have interchangeable designations.
